Nureca Ltd
Incorporated in 2016, Nureca Ltd is in the business of home healthcare and wellness products[1]
- Market Cap ₹ 251 Cr.
- Current Price ₹ 251
- High / Low ₹ 448 / 198
- Stock P/E 296
- Book Value ₹ 194
- Dividend Yield 0.00 %
- ROCE 1.29 %
- ROE 0.44 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of 1.98% over past five years.
- Company has a low return on equity of -2.72% over last 3 years.
- Earnings include an other income of Rs.12.4 Cr.
- Company's cost of borrowing seems high
- Promoter holding has decreased over last 3 years: -5.70%
- Working capital days have increased from 261 days to 445 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: E-Commerce/App based Aggregator Industry: Trading
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 62 | 99 | 213 | 256 | 111 | 92 | 110 | |
| 53 | 90 | 152 | 200 | 126 | 102 | 117 | |
| Operating Profit | 9 | 10 | 62 | 56 | -15 | -10 | -8 |
| OPM % | 15% | 10% | 29% | 22% | -13% | -11% | -7% |
| 0 | 0 | 3 | 8 | 7 | 11 | 12 | |
| Interest | 0 | 1 | 2 | 1 | 0 | 0 | 1 |
| Depreciation | 0 | 0 | 0 | 1 | 2 | 2 | 2 |
| Profit before tax | 9 | 9 | 62 | 61 | -11 | -3 | 1 |
| Tax % | 30% | 26% | 26% | 26% | -23% | -30% | 37% |
| 6 | 6 | 46 | 45 | -8 | -2 | 1 | |
| EPS in Rs | 6,230.00 | 6,400.00 | 46.37 | 44.96 | -8.25 | -1.79 | 0.85 |
| Dividend Payout % | 0% | 0% | 4% | 7% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | -25% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -33% |
| 3 Years: | -73% |
| TTM: | 114% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -39% |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | -3% |
| Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 8 | 15 | 153 | 193 | 185 | 183 | 184 |
| 0 | 10 | 4 | 4 | 3 | 3 | 5 | |
| 15 | 9 | 19 | 12 | 8 | 10 | 11 | |
| Total Liabilities | 24 | 34 | 186 | 219 | 207 | 205 | 210 |
| 1 | 1 | 4 | 10 | 9 | 7 | 9 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 33 | 59 | 94 | 1 |
| 23 | 33 | 182 | 175 | 139 | 104 | 200 | |
| Total Assets | 24 | 34 | 186 | 219 | 207 | 205 | 210 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 0 | -8 | 35 | 1 | 10 | -3 | -19 | |
| -0 | -0 | -110 | -3 | -16 | 18 | 8 | |
| -0 | 8 | 92 | -7 | -2 | -1 | -0 | |
| Net Cash Flow | 0 | -0 | 17 | -9 | -8 | 14 | -11 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 52 | 47 | 0 | 4 | 14 | 6 | 11 |
| Inventory Days | 123 | 93 | 135 | 174 | 167 | 186 | 214 |
| Days Payable | 89 | 33 | 32 | 13 | 24 | 31 | 35 |
| Cash Conversion Cycle | 87 | 107 | 103 | 165 | 157 | 161 | 190 |
| Working Capital Days | 45 | 85 | 62 | 111 | 160 | 179 | 445 |
| ROCE % | 57% | 67% | 33% | -6% | -4% | 1% |
Documents
Announcements
-
Announcement Under Regulation 30
2d - Board approved merger of subsidiary and strike-off of non-material subsidiary for efficiency.
-
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations
And Disclosure Requirements) Regulations, 2015
2d - Board approved merger of subsidiary and strike-off of non-functional subsidiary for simplification.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
7 May - Nureca Limited has informed regarding Newspaper Publication.
-
Announcement under Regulation 30 (LODR)-Resignation of Director
6 May - Independent Director Vikram Chaudhery resigns immediately citing personal reasons and commitments.
-
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
6 May - Approved FY25 audited results; appointed new auditors; approved merger of subsidiary; re-appointed directors; scheduled 9th AGM.
Business Overview:[1]
Nureca Limited operates as a digital-first healthcare company with a diverse and innovative portfolio catering to the home healthcare and wellness segment. The company is recognized for its flagship brand Dr Trust and focuses on delivering high-quality, accessible, and technology-driven solutions to customers.